Physician profile
Michael E Herzog
NPI 1639197957
$8,154.80
in general payments reported to CMS, 2019-2025
46 companies · $1,333 in 2025
The $1,333 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $446 · 2021: $874 · 2022: $1,143 · 2023: $1,385 · 2024: $1,532 · 2025: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,151 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,150.62 |
| Education | $100.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,489.07 | 2019-2020 | |
| Abbvie INC. | $743.82 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $529.28 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $520.42 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $444.78 | 2019-2025 | Xtandi, Myrbetriq |
| Allergan, INC. | $405.63 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $381.55 | 2023-2025 | Provenge |
| Calyxo, INC. | $345.92 | 2024-2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $254.10 | 2019-2025 | Ams 700, Rezum Generator, Greenlight Xps |
| Janssen Biotech, INC. | $247.22 | 2019-2025 | Erleada |
| 180 Medical, INC. | $239.43 | 2022-2025 | |
| Antares Pharma, INC. | $237.17 | 2019-2025 | Xyosted |
| Axonics, INC. | $216.71 | 2022-2024 | Axonics, Bulkamid |
| Coloplast Corp | $191.35 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $177.96 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $167.91 | 2021-2022 | |
| Srs Medical Systems, INC. | $143.48 | 2021 | |
| Olympus America INC. | $139.78 | 2020-2022 | |
| Medtronic, INC. | $122.19 | 2023-2024 | Interstim |
| Novartis Pharmaceuticals Corporation | $113.24 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.56 | 2022-2025 | |
| Tolmar, INC. | $96.03 | 2023-2025 | Jatenzo |
| Urogen Pharma, INC. | $90.70 | 2023-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $62.27 | 2023-2025 | Imfinzi, Lynparza |
| Ferring Pharmaceuticals INC. | $59.60 | 2024-2025 | Adstiladrin |
| Accord Healthcare, INC. | $56.88 | 2023-2024 | |
| Bioprotect Medical, INC. | $54.47 | 2024-2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $53.28 | 2022-2025 | Keytruda |
| Myovant Sciences INC. | $52.38 | 2021-2022 | |
| Endo USA, INC. | $47.91 | 2024-2025 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $36.49 | 2022-2024 | Prolaris |
| Blue Earth Diagnostics | $35.96 | 2021-2022 | |
| Ambu INC. | $32.04 | 2020 | |
| Rochester Medical Corporation | $28.68 | 2021 | |
| Clarus Therapeutics INC. | $25.24 | 2021 | |
| Genzyme Corporation | $24.17 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.12 | 2019 | |
| Glaxosmithkline, LLC. | $21.82 | 2023 | Arexvy, Shingrix |
| Immunitybio, INC. | $20.68 | 2025 | |
| Bluewind Medical | $19.24 | 2024 | Revi |
| Verity Pharmaceuticals INC. | $19.02 | 2024 | Trelstar |
| Pfizer INC. | $18.08 | 2025 | |
| Cardinal Health 414 LLC | $17.32 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $15.82 | 2021 | |
| Halozyme INC | $14.97 | 2023 | |
| Avation Medical, INC. | $14.06 | 2025 | Vivally System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Herzog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.